Aeovian Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted and highly selective small molecules to restore cellular metabolic quality control, thereby addressing the dysregulated growth and hyperactive signaling found in certain rare genetic and age-related diseases.Our lead development candidate, AV078, is a first-in-class CNS penetrant selective mTORC1 inhibitor being developed for the treatment of TSC refractory epilepsy and is currently being evaluated in a Phase 1 trial. TSC is a rare genetic disorder caused by the hyperactive signaling of mTORC1.Beyond AV078, we’ve developed a proprietary library of small molecules, which are potent and selective mTORC1 and CD38 inhibitors that have the potential to precisely target the underlying biology of multiple rare and age-related disease
View Top Employees from Aeovian PharmaceuticalsWebsite | http://www.aeovian.com |
Employees | 9 (2 on RocketReach) |
Address | 2930 Domingo Ave # 145, Berkeley, California 94705, US |
Technologies |
JavaScript,
HTML,
Twitter
+9 more
(view full list)
|
Industry | Biotechnology Research, Biopharma, Biotechnology, Health Care, Science and Engineering, Pharmaceutical |
Looking for a particular Aeovian Pharmaceuticals employee's phone or email?
Justin Gover is the Board Member of Aeovian Pharmaceuticals.
2 people are employed at Aeovian Pharmaceuticals.
Aeovian Pharmaceuticals is based in Berkeley, California.